Targeting Plasmodium PI(4)K to eliminate malaria. by McNamara, C, Lee, M, Lim, C, Lim, S, Roland, J, Nagle, A, Simon, O, Yeung, B, Chatterjee, A, McCormack, S, Manary, M, Zeeman, A, Dechering, K, Kumar, T, Henrich, P, Gagaring, K, Ibanez, M, Kato, N, Kuhen, K, Fischli, C, Rottmann, M, Plouffe, D, Bursulaya, B, Meister, S, Rameh, L

Targeting Plasmodium PI(4)K to eliminate malaria by McNamara, C, Lee, M, Lim, C, Lim, S, Roland, J, Nagle, A, Simon, O, Yeung, B, Chatterjee, A, McCormack, S, Manary, M, Zeeman, A, Dechering, K, Kumar, T, Henrich, P, Gagaring, K, Ibanez, M, Kato, N, Kuhen, K, Fischli, C, Rottmann, M, Plouffe, D, Bursulaya, B, Meister, S, Rameh, L

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling. by Le Bihan, A, de Kanter, R, Angulo-Barturen, I, Binkert, C, Boss, C, Brun, R, Brunner, R, Buchmann, S, Burrows, J, Dechering, K, Delves, M, Ewerling, S, Ferrer, S, Fischli, C, Gamo-Benito, F, Gnädig, N, Heidmann, B, Jiménez-Díaz, M, Leroy, D, Martínez, M, Meyer, S, Moehrle, J, Ng, C, Noviyanti, R, Ruecker, A, Sanz, L, Sauerwein, R, Scheurer, C, Schleiferboeck, S, Sinden, R, Snyder, C, Straimer, J, Wirjanata, G, Marfurt, J, Price, R, Weller, T, Fischli, W, Fidock, D, Clozel, M, Wittlin, S